Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced the appointment of Joseph Bolen, Ph.D., as Chief ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, ...

Mergers & Aquisitions Call March 26, 2025 6:30 PM ETCompany ParticipantsNeil Rossy - President and CEOPatrick Bui ...

BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

Chewy's customer-first service model underpins its strong brand, allowing the firm to amass a customer base of more than 20 million annual active members, with robust subscription penetration and ...

Christianity in China has stopped growing since 2010, according to an academic paper. "In 19 nationally representative ...

Nvidia’s lead is poised to last for years, as its proprietary hardware and software are best in class. The company’s revenue is forecast ... Examples of the trend include Meta investing $10 billion in ...

Strengthened leadership team with key appointments, including Barry Quart, Pharm.D. as CEO, and David Szekeres as President, bringing deep clinical, regulatory, operational and strategic expertise ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...

The advertisement of Gauhati University Jobs 2025 is out in the official website. The recruitment process is underway for the ...